HOME >> MEDICINE >> NEWS
Depression-treating drugs lead record-setting pharmacy benefit cost rise -- Total increase lower when pharmacy benefit actively managed

ST. LOUIS, June 29, 1999 -- America's growing use of depression-treating drugs like Prozac, Zoloft and Paxil made antidepressants the biggest contributors to a record-setting pharmacy benefit cost increase of 16.8 percent last year, according to a study by the country's largest independent pharmacy benefit manager, Express Scripts, Inc.

Not everyone was hit by the full cost increase. "Plan sponsors that successfully navigated the challenging pharmacy landscape were able to cut the cost increase in half by actively managing their pharmacy benefit to encourage the use of lower cost but equally effective and safe drugs," said Barrett Toan, chief executive officer of Express Scripts.

For consumers, the cost increases mean they will pay a bigger share of the expense in the form of higher copayments ranging from $5 for generic drugs to $25 or more for selected, single source brands. Employers and other pharmacy benefit plan sponsors currently pay as much as 80 percent of a prescription's cost which can amount to more than a hundred dollars each in some cases.

Plan sponsors used carefully constructed formularies, three tier copayments and other approaches to control costs and maintain access to pharmacy benefits despite the discovery of more innovative drugs, faster FDA approvals and more widespread direct-to-consumer marketing, according to Toan.

Last year's annual per member cost -- on an average wholesale price (AWP) basis before copayments, discounts and active management -- was $329.48 up from $282.48 in 1997. New drugs introduced since 1992 accounted for 35.6 percent or $117.55 of the 1998 pharmacy benefit cost. A single prescription for a post-1992 new drug cost an average of $72 in 1998.

The unmanaged AWP cost increase was the largest reported by Express Scripts since 1993, when the company began monitoring drug cost and utilization trends among its members, which now number 47 million. Another increase of more than 16 percent is
'"/>

Contact: Steve Littlejohn
slittlejohn@kupperparker.com
314-290-2024
Kupper Parker Communications
29-Jun-1999


Page: 1 2 3 4

Related medicine news :

1. UW research shows risk factors for relapse among health care professionals who abuse drugs
2. New studies show mixed results on epilepsy drugs and birth defects
3. Newly discovered pathway might help in design of cancer drugs
4. Study examines consequences of Thailands war on drugs
5. Computational tool predicts how drugs work in cells, advancing efforts to design better medicines
6. Three anti-platelet drugs used in combination are safe
7. HIV patients may be at risk of heart problems when taking protease inhibitor drugs
8. Clot-busting drugs may help detect potentially deadly leg clots
9. Herb used to treat diabetes works like modern-day prescription drugs, study suggests
10. Penn study shows how next-generation diabetic drugs could work more selectively
11. Study shows drugs such as Vioxx and Celebrex were widely over-used long before recent problems

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... -- West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today announced that it will release third-quarter 2017 ... 26, 2017, and will follow with a conference call ... a.m. Eastern Time. To participate on the call, please ... is 94093362. A ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
(Date:10/11/2017)... -- Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an ... Puerto Rico , where the company ... Following a comprehensive onsite assessment, ... damage, temporary loss of power and minimal water damage ... operations have resumed, and the company expects to return ...
Breaking Medicine Technology:
Cached News: